TipRanks
Jazz Pharmaceuticals (MX:JAZZN)
:JAZZN
Mexico Market
JAZZN
Jazz Pharmaceuticals
RESEARCH TOOLSreports

Jazz Pharmaceuticals (JAZZN) Stock News & Sentiment

0 Followers
Jazz Pharmaceuticals Acquires Actio Biosciences to Expand Epilepsy Portfolio
Premium
Company Announcements
Jazz Pharmaceuticals Acquires Actio Biosciences to Expand Epilepsy Portfolio
7d ago
8K
JAZZ
Jazz Pharmaceuticals: Ziihera’s Strong 1L GEA Profile Supports Reiterated Buy Rating and Unchanged $300 Price Target
Premium
Ratings
Jazz Pharmaceuticals: Ziihera’s Strong 1L GEA Profile Supports Reiterated Buy Rating and Unchanged $300 Price Target
21d ago
JAZZ
Jazz Pharmaceuticals Completes $1.25 Billion Notes Offering
Premium
Company Announcements
Jazz Pharmaceuticals Completes $1.25 Billion Notes Offering
21d ago
8K
JAZZ
Jazz wins FDA nod for Ziihera gastric cancer use
Premium
Company Announcements
Jazz wins FDA nod for Ziihera gastric cancer use
27d ago
8K
JAZZ
Jazz Pharmaceuticals Advances Phase 3 Xywav Dosing Study in Sleep Disorders
Premium
Company Announcements
Jazz Pharmaceuticals Advances Phase 3 Xywav Dosing Study in Sleep Disorders
1M ago
JAZZ
Jazz Pharmaceuticals Buy Rating Reaffirmed as Actio Acquisition Bolsters Rare Epilepsy Pipeline; $300 Price Target Maintained
Premium
Ratings
Jazz Pharmaceuticals Buy Rating Reaffirmed as Actio Acquisition Bolsters Rare Epilepsy Pipeline; $300 Price Target Maintained
1M ago
JAZZ
Jazz Pharmaceuticals to Acquire Actio Biosciences in Merger
Premium
Company Announcements
Jazz Pharmaceuticals to Acquire Actio Biosciences in Merger
1M ago
8K
JAZZ
More MX:JAZZN News >

JAZZN News on the Web

Jazz Pharmaceuticals (JAZZ) Places An $820M Epilepsy Bet
Insider Monkey
Neutral
Jazz Pharmaceuticals PLC at Citi Biopharma Back to School Summit Transcript
GuruFocus News
Neutral
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Bullish
Jazz (JAZZ) Says Ziihera Beat Trastuzumab on Overall Survival. Can it Replace the First-Line HER2 Backbone?
Insider Monkey
Bullish
Why Is Jazz (JAZZ) Down 6.9% Since Last Earnings Report?
Zacks
Neutral
Jazz Prices Upsized $1.1 Bln Exchangeable Notes Offering, Plans $225 Mln Share Repurchase
rttnews
Bullish
Roche receives FDA approval for companion diagnostic tests for Ziihera
TipRanks News
Bullish
Jazz Pharmaceuticals price target raised to $300 from $287 at Deutsche Bank
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
MX:JAZZN
Sector Average
Media Buzz
This Week3 articles
Weekly Average10 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MX:JAZZN’s Media Buzz Sentiment?
3 articles about MX:JAZZN were published this week. In an average week, 10 articles are published.
    What is MX:JAZZN’s weekly average amount of articles?
    In an average week, 10 articles about MX:JAZZN are published.
      What is MX:JAZZN’s News Sentiment?
      100% of articles about MX:JAZZN were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        CRLCharles River Labs
        RCKTRocket Pharmaceuticals
        MRNAModerna
        HITIHigh Tide
        ASNDAscendis Pharma
        Showing the stocks with the most bullish news sentiment over the past week